Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma
Barbara Jezeršek Novaković, Lučka Boltežar, Aleksander NovakovićDivision of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, 1000, SloveniaCorrespondence: Barbara Jezeršek NovakovićDivision of Medical Oncology, Institute of Oncology Ljubljana, Zaloška 2,...
Main Authors: | Jezeršek Novaković B, Boltežar L, Novaković A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-03-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/current-opinion-on-pixantrone-in-the-treatment-of-non-hodgkin-b-cell-l-peer-reviewed-article-TCRM |
Similar Items
-
Immunotoxin – a new treatment option in patients with relapsed and refractory Hodgkin lymphoma
by: Novakovic Barbara Jezersek
Published: (2015-12-01) -
Pixantrone Sensitizes Gram-Negative Pathogens to Rifampin
by: Pengfei She, et al.
Published: (2022-12-01) -
BRIDGING TO TRANSPLANT IN DIFFUSE LARGE B CELL LYMPHOMA
by: Christian Gisselbrecht, et al.
Published: (2016-07-01) -
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group
by: G. Santini, et al.
Published: (2004-05-01) -
Linfomas B y T: Diagnóstico inmunofenotípico de los linfomas no hodgkinianos B-and T-lymphomas. Immunophenotypical diagnosis of non-Hodgkin lymphomas
by: Bertha B Socarrás Ferrer, et al.
Published: (2003-04-01)